Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply Partin and Powell raise an important issue in decision making: what is the optimal amount and type of information that patients should consider in a decision support intervention? They suggest that 2 of the types of information we presented, information about risk of mortality from prostate cancer and information about the risks associated with treatment complications, are the most important, while the other 2 (risk of undergoing a biopsy as a result of screening and risk of being [over]diagnosed) seem less important to them.
Pignone MP. If Less Is More, Which Outcomes Should Be Presented in Facilitating Prostate Cancer Screening Decision Making?—Reply. JAMA Intern Med. 2013;173(17):1657. doi:10.1001/jamainternmed.2013.8132